Mair, Maximilian J.
Kiesel, Barbara
Feldmann, Katharina
Widhalm, Georg
Dieckmann, Karin
Wöhrer, Adelheid
Müllauer, Leonhard
Preusser, Matthias
Berghoff, Anna S. http://orcid.org/0000-0001-9379-6797
Funding for this research was provided by:
Christian Doppler Forschungsgesellschaft
National Foundation for Research, Technology and Development
Bundesministerium für Digitalisierung und Wirtschaftsstandort
Medical University of Vienna
Article History
Received: 27 January 2021
Accepted: 15 February 2021
First Online: 2 March 2021
Declarations
:
: Matthias Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen. The following for-profit companies have supported clinical trials and contracted research conducted by MP with payments made to his institution: Boehringer-Ingelheim, Bristol-Myers Squibb, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie. Anna Sophie Berghoff has received research support from Daiichi Sankyo, Roche, and honoraria for lectures, consultation or advisory board participation from Roche, Bristol-Meyers Squibb, Merck, Daiichi Sankyo as well as travel support from Roche, Amgen and AbbVie. All other authors declare that they have no conflict of interest related to the present study.
: This study was performed according to the ethical standards of the Ethics Committee of the Medical University of Vienna (approval no. 1166/2019) and the Helsinki Declaration of 1964 and its amendments.